Oxaliplatin Injection, Solution
Product Images NDC 72603-101

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 72603-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Nor0i 0001 01)

Chemical structure of Oxaliplatin, showing a platinum (Pt) atom coordinated with a cyclohexane ring containing two amine (NH2) groups and two oxalate groups (O-C=O). The diagram illustrates the molecular connectivity typical for this platinum-based chemotherapy agent.*

FDA Label Image

Figure 1 (Nor0i 0001 02)

A Kaplan-Meier survival curve chart showing disease progression-free survival (PFS) probability over time in months for two treatment arms labeled POLPOX4 and LV5FU2. The chart includes a legend detailing the number and percentage of events per arm, a hazard ratio with confidence interval, a stratified logrank test p-value, and a table showing the number of patients at risk at various time points.*

FDA Label Image

Figure 2 (Nor0i 0001 03)

A Kaplan-Meier survival curve chart depicting disease-free survival (DFS) probability over time in months, comparing different treatment arms in Stage III patients. The graph includes a hazard ratio with confidence interval and a p-value from a logrank test.*

FDA Label Image

Figure 3 (Nor0i 0001 04)

A Kaplan-Meier survival curve graph showing the percentage of patients surviving over 24 months for three treatment groups: Oxaliplatin plus 5-FU/LV, Oxaliplatin plus Irinotecan, and Irinotecan plus 5-FU/LV. Survival percentages decline over time, with median survival times noted for each group. The graph includes a p-value indicating statistical significance for comparison.*

FDA Label Image

Principal Display Panel – Oxaliplatin Injection, Usp 50 mg Vial Label (Nor0i 0001 05 02)

Oxaliplatin injection, USP 50 mg per 10 mL (5 mg per mL) sterile aqueous solution for intravenous use. The single-dose vial is preservative-free and labeled as a cytotoxic agent. Manufactured for NorthStar Rx LLC by Gland Pharma Limited in India, the label includes storage instructions and dilution warnings.*

FDA Label Image

Principal Display Panel – Oxaliplatin Injection, Usp 50 mg Carton (Nor0i 0001 06 02)

Oxaliplatin Injection, USP 50 mg per 10 mL (5 mg per mL) is an intravenous solution presented in a single-dose 10 mL vial. The label indicates it is a sterile, preservative-free aqueous solution, cytotoxic agent, and should not be mixed with sodium chloride solutions. Manufactured for NorthStar Rx LLC by Gland Pharma Limited, the packaging includes storage and handling instructions and a barcode.*

FDA Label Image

Principal Display Panel – Oxaliplatin Injection, Usp 100 mg Vial Label (Nor0i 0001 07 02)

Label for Oxaliplatin Injection, USP 100 mg per 20 mL (5 mg per mL) intravenous solution by NorthStar Rx LLC. The label includes storage instructions, usage warnings including it as a cytotoxic agent, and manufacturing details from NorthStar Rx LLC and Gland Pharma Limited in India. It specifies the product is preservative-free sterile aqueous solution and single-dose vial.*

FDA Label Image

Principal Display Panel – Oxaliplatin Injection, Usp 100 mg Carton (Nor0i 0001 08 02)

Oxaliplatin Injection, USP 100 mg per 20 mL (5 mg per mL) single-dose vial label. For intravenous use only, cytotoxic agent. Manufactured for NorthStar Rx LLC by Gland Pharma Limited. Sterile aqueous solution, preservative-free. Includes storage instructions and warnings not to mix or add to sodium chloride-containing solutions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.